1. Home
  2. OZK vs GKOS Comparison

OZK vs GKOS Comparison

Compare OZK & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank OZK

OZK

Bank OZK

HOLD

Current Price

$48.29

Market Cap

5.2B

Sector

Finance

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$111.63

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OZK
GKOS
Founded
1903
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.4B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
OZK
GKOS
Price
$48.29
$111.63
Analyst Decision
Buy
Strong Buy
Analyst Count
9
13
Target Price
$55.38
$123.62
AVG Volume (30 Days)
1.0M
860.2K
Earning Date
01-15-2026
10-29-2025
Dividend Yield
3.61%
N/A
EPS Growth
1.97
N/A
EPS
6.20
N/A
Revenue
$1,539,084,000.00
$469,820,000.00
Revenue This Year
$17.94
$31.15
Revenue Next Year
$0.86
$24.15
P/E Ratio
$7.85
N/A
Revenue Growth
5.38
30.38
52 Week Low
$35.71
$73.16
52 Week High
$53.66
$163.71

Technical Indicators

Market Signals
Indicator
OZK
GKOS
Relative Strength Index (RSI) 61.92 75.09
Support Level $46.47 $105.88
Resistance Level $49.28 $110.87
Average True Range (ATR) 0.99 3.32
MACD 0.39 0.03
Stochastic Oscillator 74.82 100.00

Price Performance

Historical Comparison
OZK
GKOS

About OZK Bank OZK

Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit, and individual retirement accounts to loan services like real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking, and other related services.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: